Table 3 Dose coverage detailed in patients with tumor recurrence
ID | Prescribed dose | EUD PTV | D98 GTVini | D98 GTVrt | D98 progression | D98 growth zone | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Gy | % | Gy | % | Gy | % | Gy | % | |||
1 | 54.0 | 52.20 | 51.1 | 94.6 | 50.25 | 93.1 | 49.85 | 92.3 | 50.25 | 93.1 |
2 | 60.0 | 57.50 | 53.5 | 89.2 | 53.48 | 89.1 | 53.28 | 88.8 | 58.58 | 97.6 |
3 | 60.0 | 59.20 | 58.45 | 97.4 | 58.45 | 97.4 | 58.05 | 96.8 | 58.45 | 97.4 |
4 | 59.4 | 59.40 | 57.35 | 96.5 | 57.75 | 97.2 | 58.35 | 98.2 | 58.35 | 98.2 |
5 | 60.0 | 51.40 | 53.15 | 88.6 | 26.00 | 43.3 | 52.85 | 88.1 | 52.75 | 87.9 |
6 | 60.0 | 55.50 | 58.03 | 96.7 | 57.98 | 96.6 | 57.78 | 96.3 | 57.98 | 96.6 |
7 | 60.0 | 58.90 | 56.15 | 93.6 | 56.15 | 93.6 | 55.45 | 92.4 | 56.05 | 93.4 |